Nemagen

1 known investors

NemaGen Discoveries is an early-phase biotech company developing first-in-class therapies for patients with allergic inflammation and mast cell-related diseases. Its technologies are based on studying the body's natural mechanisms for preventing inflammation following parasitic infections.